Drugs Approved for Thyroid Cancer - National Cancer Institute

Drugs Approved for Thyroid Cancer - National Cancer Institute

Drugs Approved for Thyroid Cancer

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for thyroid cancer. The list includes generic names and brand names. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in thyroid cancer that are not listed here.

Drugs Approved for Thyroid Cancer

• Cabozantinib-S-Malate
• Caprelsa (Vandetanib)
• Cometriq (Cabozantinib-S-Malate)
• Dabrafenib Mesylate
• Doxorubicin Hydrochloride
• Lenvatinib Mesylate
• Lenvima (Lenvatinib Mesylate)
• Mekinist (Trametinib)
• Nexavar (Sorafenib Tosylate)
• Sorafenib Tosylate
• Tafinlar (Dabrafenib Mesylate)
• Trametinib
• Vandetanib

Related Resources

• Thyroid Cancer—Patient Version
• Chemotherapy and You: Support for People With Cancer

• Updated: June 10, 2019